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include obviating the need for aortic cross-clamping,
avoiding general anesthesia, and avoiding thoracic or tho-
racoabdominal incisions in this frequently debilitated pop-
ulation. One published series has demonstrated the
feasibility of endoluminal therapy with acceptable inter-
mediate-term outcomes in a cohort where 60% were
deemed nonsurgical candidates.10 However, this experi-
ence and several other smaller series have reported the
occurrence of neurologic deficits.10,12-15 We reviewed the
three cases of clinically evident spinal cord ischemia
observed in our experience with 53 endovascular TAA
exclusions in an attempt to delineate factors that con-
tributed to their development.
PATIENTS AND METHODS
From May 1997 to April 2001, 53 patients underwent
endoluminal exclusion of their TAA at Mount Sinai
Medical Center. Informed consent was obtained, and all
procedures were performed under protocol approved by
the Institutional Review Board. Preoperative spiral com-
puted tomography (CT) scanning and angiography were
performed in all patients to determine aortic anatomy and
obtain measurements for endograft sizing. The locations
of patent intercostal arteries in relation to the aneurysm
and the requisite proximal and distal endograft landing
zones were noted, with an attempt made to minimize
endograft coverage of these vessels. Selective intercostal
artery angiography was not performed. All endovascular
TAA repairs were performed in the operating room.
Spinal cord ischemia is a devastating complication of
surgical repair of aneurysms involving the thoracic aorta.
Despite refinements in surgical technique and the use of
adjunctive measures for spinal cord protection, the risk of
postoperative neurologic deficit remains significant.1 A
multimodality approach has proven effective in reducing
the incidence of spinal cord ischemia in many series; how-
ever, the risk has not been eliminated.2-7 The dismal nat-
ural history of untreated thoracic aortic aneurysms (TAAs)
and thoracoabdominal aortic aneurysms (TAAAs) and the
decision to intervene must be carefully balanced against
the extensive comorbid illnesses frequently present in this
patient population.8,9
Endovascular treatment of TAAs holds the allure of
reducing periprocedural complications while expanding
the number of patients who can be offered treatment for
their disease. Benefits of the endovascular approach
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Background: Surgical repair of thoracoabdominal aneurysms may be associated with a significant risk of perioperative
morbidity including spinal cord ischemia, which occurs at a rate of between 5% and 21%. Spinal cord ischemia after
endovascular repair of thoracic aortic aneurysms (TAAs) has also been reported. This investigation reviews the occur-
rence of spinal cord ischemia after endovascular repair of descending TAAs at the Mount Sinai Medical Center.
Patients and Methods: Between May 1997 and April 2001, 53 patients underwent endovascular exclusion of their TAA.
Preprocedure computed tomography scanning and angiography were performed on all patients. All were performed in
the operating room using C-arm fluoroscopy. Physical examinations and computed tomography scans were performed
at discharge and at 1, 3, 6, and 12 months postoperatively and then annually thereafter. Spinal cord ischemia devel-
oped in three of the 53 patients (5.7%) postoperatively. In one patient, cord ischemia developed that manifested as early
postoperative left leg weakness occurring after concomitant open infrarenal abdominal and endovascular TAA repair.
The neurologic deficit resolved 12 hours after spinal drainage, steroid bolus, and the maintenance of hemodynamic sta-
bility. The remaining two patients developed delayed onset paralysis, one patient on the second postoperative day and
the other patient 1 month postrepair. Both of these patients had previous abdominal aortic aneurysm repair, and both
required long grafts to exclude an extensive area of their thoracic aortas. Irreversible cord ischemia and paralysis
occurred in both of these patients.
Conclusions: Endovascular repair of TAA has shown a promising reduction in operative morbidity; however, the risk of
spinal cord ischemia remains. Concomitant or previous abdominal aortic aneurysm repair and long segment thoracic
aortic exclusion appear to be important risk factors. Spinal cord protective measures (ie, cerebrospinal fluid drainage,
steroids, prevention of hypotension) should be used for patients with the aforementioned risk factors undergoing
endovascular TAA repair. (J Vasc Surg 2001;34:997-1003.)
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Endografts were placed via femoral, iliac, or abdominal
aortic arterial access under C-arm fluoroscopic guidance.
Endografts used include the Vanguard (Boston Scientific,
Natick, Mass), Talent (Medtronic AVE, Minneapolis,
Minn), and TAG Excluder (W. L. Gore and Associates,
Flagstaff, Ariz). The mechanisms used for graft deploy-
ment have been previously described, and deployment cri-
teria include a minimum of 15 mm of aortic neck for
proximal and distal stent graft anchoring and 30 mm of
stent graft modular overlap for sealing in multiple-module
devices.11 Patients were followed with physical examina-
tion and CT scanning at discharge and at 1, 3, 6, and 12
months and then annually thereafter.
Three patients (5.7%) manifested postoperative neuro-
logic deficits referable to spinal cord ischemia, all of
delayed onset. All three patients were high-risk candidates
for open surgical repair based upon comorbid medical
conditions (Table). Each case is summarized below.
Case 1. A 78-year-old woman with severe chronic
obstructive pulmonary disease had successful deployment
of the first of two TAG Excluder devices measured for
elective exclusion of her 8-cm mid-descending TAA. As a
result of operator error, the second device was deployed
too low, thereby crossing the visceral segment of the
abdominal aorta, with resulting obstruction of the celiac,
superior mesenteric, and renal arteries (Fig 1, A). Retrieval
of the misdeployed endograft was accomplished via an
infrarenal aortotomy. Primary repair of the infrarenal aorta
could not be performed safely because of the aneurysmal
dilatation of her abdominal aorta (4 cm in diameter).
Tube graft repair of the abdominal aortic aneurysm (AAA)
was performed. TAA exclusion was then completed using
a side-arm limb sewn to the infrarenal tube graft for aortic
access. Completion angiogram revealed complete thoracic
aneurysm exclusion and patent visceral vessels (Fig 1, B),
with the distal extent of the stent graft to the T11 level.
The patient’s neurologic examination was completely nor-
mal for the first 8 hours immediately after the surgery.
During the first postoperative night, the patient had two
episodes of moderate hypotension (systolic blood pres-
sures, 90 mm Hg) which responded to isotonic fluid
resuscitation. Soon thereafter, she reported left leg paraly-
sis and right leg weakness, associated with a decreased sen-
sation to the T11 level. A lumbar cerebrospinal fluid
drainage catheter was placed (opening pressure, 8 cm of
water), and 40 mL of cerebrospinal-fluid were initially
withdrawn through the spinal drainage catheter. The over-
flow pressure for the cerebrospinal fluid drainage catheter
was set at 10 cm of water, and during the next 48 hours,
460 cc drained. Two mg dexamethasone was administered
intravenously every 8 hours and mean arterial pressure
maintained at approximately 90 mm Hg. The spinal cord
appearance was noted to be unremarkable on magnetic
resonance imaging (MRI). Dramatic improvement in the
neurologic deficit was seen in the first 12 hours, with com-
plete resolution of all neurologic sequelae by the third
postoperative day. The cerebrospinal fluid drainage
catheter was removed on postoperative day three. The
patient was discharged home on postoperative day seven
on an oral steroid taper and has remained free of deficit
during a follow-up period of 18 months.
Case 2. A 70-year-old man with chronic obstructive
pulmonary disease, hypertension, chronic renal insuffi-
ciency, previous AAA repair, and previous left thoraco-
tomy for lung cancer resection required a total of five
modular Talent endografts to exclude his asymptomatic
aneurysm seen to involve the entire descending thoracic
aorta. Bare stent struts at the proximal and distal ends
were used to allow placement of the device across the left
subclavian artery proximally and cephalad to the celiac axis
distally, approaching the T11 level. The use of five mod-
ules allowed for greater length and flexibility of aneurysm
coverage; however, multiple modules increase the poten-
tial for junctional endoleak. After successful exclusion of
the TAA, the patient was discharged home on postopera-
tive day two with a normal neurologic examination. The
patient presented to his physician 4 weeks later having had
2 days of bilateral leg weakness. Vital signs were normal.
Neurology consultation identified an L1 radiculopathy
with a myelopathy. MRI did not show evidence of cord
compression or infarction. The patient’s symptoms had
improved after hospitalization, with no specific treatment
initiated. An electromyogram showed L1 level radicular
dysfunction, indicating ischemia of the anterior horn cells
at the corresponding spinal cord level, without infarction.
He was discharged on hospital day four to receive outpa-
tient physical therapy. Six weeks later, he presented to the
emergency department with bilateral lower-extremity
paralysis, having had 3 days of progressive lower-extremity
weakness. Again, vital signs were normal. A cerebrospinal
fluid drainage catheter was inserted, but with no effect.
Fig 1. Case 1. A, Stent graft deployed across visceral vessels.
Guidewire was positioned in celiac axis (arrow) before deploy-
ment of second device to mark location of celiac axis. B, Patent
visceral vessels demonstrated after device extraction and comple-
tion of TAA exclusion.
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Urologic work-up of worsening chronic renal failure
revealed a left ureteral obstruction with hydronephrosis
from a ureteral tumor. A percutaneous nephrostomy tube
was placed for decompression. CT examination of the tho-
racic aorta revealed aneurysm exclusion without evidence
of stent migration. The patient remains paraplegic at 11-
month follow-up.
Case 3. A 69-year-old man with coronary artery dis-
ease, chronic obstructive pulmonary disease, and hyper-
tension had successful exclusion of an asymptomatic,
multilobed descending thoracic aneurysm using three
modular Talent thoracic endovascular devices (Fig 2, A).
Abdominal aortic angiogram revealed an absence of lum-
bar arteries secondary to his previous AAA repair but
patent distal thoracic intercostal arteries proximal to the
celiac axis (Fig 2, B). The endoprosthesis extended from 1
cm distal to the left subclavian artery to 2 cm proximal to
the celiac axis. Postdeployment angiogram revealed no
endoleak and preservation of flow through the intercostal
arteries immediately proximal to the celiac axis through
bare stent struts (Fig 2, C). However, intercostal vessels
were recognized to be compromised at the T8 level. His
postoperative course was uneventful, and he was dis-
charged to home the following day with a normal neuro-
logic examination. On postoperative day two, the patient
developed bilateral lower-extremity weakness that pro-
gressed to dense bilateral lower-extremity paraplegia over
a 2-day period. Cerebrospinal fluid drainage was unsuc-
cessful in impacting degree of neurologic deficit. There
were no recorded episodes of hypotension. MRI revealed
spinal cord infarction from the T10 level to the conus
medullaris. The patient had a protracted hospital course,
complicated by pneumonia, respiratory failure, sepsis, and
eventual death at 3 months from pulmonary embolism.
CT scan performed at 1 month confirmed continued
exclusion of his TAA with no endoleak or stent graft
migration.
DISCUSSION
Spinal cord ischemia and postoperative neurologic
deficit with surgical repair of TAA and TAAA are believed
to be multifactorial in etiology. Their occurrence is influ-
enced by the duration and severity of the ischemic insult,
the neuronal metabolic rate during this ischemic period,
and a subsequent reperfusion injury.1 Numerous surgical
strategies and adjuncts have been developed to prevent or
limit spinal cord ischemia, which are designed to impact at
one or more of the three stages of the ischemia cycle out-
lined above. Several therapies may be combined as part of
a multimodality method of surgical treatment and
enhanced perioperative care. Despite use of these adjuncts,
neurologic deficit still occurs, ranging from 5% to 21% in
quoted series of conventional surgical TAA and TAAA
repair.2-7
The extent of the aneurysm involvement with the tho-
racic aorta has been shown to influence the expected rate
of neurologic deficit after open TAA and TAAA repair.
Crawford type I and II aortic aneurysms or those involv-
ing the entire descending thoracic aorta portend an
increased risk, presumably because they jeopardize the T8-
L2 intercostal artery blood supply, which may be critical to
spinal cord perfusion.3,4,7 The need for an adequate seg-
ment of normal aorta proximal and distal to the TAA to
serve as graft fixation zones during endovascular exclusion
may also require the sacrifice of intercostal vessels.
Published reports of endovascular thoracic aorta repair
are limited, but spinal cord ischemia has been noted.
Greenberg et al’s12 report of neurologic deficit referable
to spinal cord ischemia in three out of 25 patients (12%)
undergoing endovascular TAA exclusion showed long-
segment thoracic aortic coverage to be a significant risk
factor in predicting clinically evident spinal cord ischemia.
Fig 2. Case 3. A, Multilobed descending TAA on preoperative
angiography. B, Celiac axis and supraceliac intercostal arteries
demonstrated on preoperative angiogram. C, Celiac axis and
supraceliac intercostal arteries demonstrated after stent graft
deployment with bare stent struts on distal aspect of device. The
arrow indicates distal extent of covered portion of endograft.
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Mitchell et al10 reported four patients (3.7%) with para-
plegia in the Stanford series of 108 patients undergoing
endovascular TAA repair. Two occurred with concomitant
open AAA repair, one with long-segment thoracic aorta
coverage and previous AAA repair, and one following
device maldeployment causing a prolonged period of aor-
tic occlusion and distal hypoperfusion.
Similar risk factors were seen in our three patients with
spinal cord ischemia. Two of our patients had both long-
segment thoracic aortic occlusion and previous AAA
repair, whereas the other’s TAA necessitated endograft
coverage of the distal thoracic aortic segment with con-
comitant AAA repair. In all cases of thoracic aortic endo-
graft placement combined with previous open AAA repair,
the absence of the normal lumbar or iliolumbar arteries
sacrificed by AAA surgery may place these TAA endograft
candidates at an increased risk for spinal cord ischemia.
Those cases with TAA stent-grafting with concomitant
open AAA repair also undergo a period of aortic cross-
clamping, potentially causing an even more severe initial
spinal cord ischemia as well as adding an element of reper-
fusion injury to the ischemic insult.
Postoperative hypotension has been postulated as an
inciting factor in delayed-onset spinal cord ischemia in
both open thoracic aortic and endovascular TAA repair,
which suggests that a marginal collateral supply after
endografting may be vulnerable to postoperative hemody-
namic compromise.12-16,18 One reported case after
endovascular repair occurred after postoperative blood
loss and subsequent myocardial infarction.15 In our series,
patient 1 did have a period of postoperative hypotension
before onset of symptoms. Her recovery began upon insti-
tution of cerebrospinal fluid drainage and steroids therapy.
Patients 2 and 3 had no precipitating event identified as a
cause for their delayed onset neurologic deficit.
Cerebrospinal fluid drainage has emerged as a poten-
tially important adjunct in reducing spinal cord ischemia in
open TAAA surgery. It has been shown to reduce early
neurologic deficit in a prospective series.5 It is thought to
promote spinal cord artery blood flow intraoperatively by
decreasing cerebrospinal fluid pressure and protecting
against the subsequent increased cerebrospinal fluid pres-
sure that accompanies reperfusion.4,5 The removal of accu-
mulated negative neurotrophic factors in the cerebrospinal
fluid may also play a role.5,17 Cerebrospinal fluid drainage
has also been shown to reverse delayed-onset neurologic
deficit after open TAAA repair.16,18 Tiesenhausen et al14
reported a case of reversible lower-extremity neurologic
deficit 12 hours after long-segment TAA endovascular
exclusion, which occurred without postoperative hemody-
namic instability. Cerebrospinal fluid drainage provided
immediate recovery. Cerebrospinal fluid drainage was insti-
tuted in the presented cases via lumbar puncture at the L3
interspace, with maintenance of pressure reduction below
the 10 cm of water pressure overflow valve setting. The
successful resolution of deficit in this patient and in patient
1 suggests a possible role for cerebrospinal fluid drainage in
the endograft patient with neurologic deficit. Of impor-
tance following endovascular grafting with the presenta-
tion of delayed-onset neurologic deficit is to rule out 
the possibility of device migration across previously patent
intercostal vessels. No graft migration was noted in our
series.
There have been two descriptions of intraoperative
strategies to predict neurologic consequences of stent
graft placement before final device deployment. Both
require the use of evoked potential monitoring. The first
report involved a 15-minute balloon occlusion of the aor-
tic segment to be excluded and the second strategy used a
retrievable stent graft deployed to exclude the aneurysm
for 20 minutes.19,20 Significant evoked potential change
might preclude the ability to deploy the final endograft.
The risks associated with both of these procedures include
additional instrumentation of a diseased aorta with result-
ing atheroembolization. In addition, the balloon occlu-
sion reintroduces the negative factor of aortic occlusion to
the endovascular procedure. Both novel strategies await
further testing. Currently, as attempts at endovascular
exclusion of thoracoabdominal aneurysms with multi–
side-branched devices are reported, measures to better
define spinal cord blood supply will be requisite.13 The
application of bare stent extension of graft fixation sites
can also preserve intercostal arteries of the adjacent aortic
segments.21
CONCLUSION
Endovascular exclusion of TAA may reduce the mor-
bidity and mortality seen with conventional surgery.
However, long-term results of efficacy are awaited. Factors
increasing the risk of neurologic deficit in endovascular
Clinical characteristics of patients manifesting postoperative spinal cord ischemia
Aneurysm Aneurysm Aneurysm Device/No. Previous
Age/sex Comorbid disease diameter (cm) length (mm) extent of modules aortic surgery
78/F COPD 8 160 mid-distal DTA Gore/2 AAA (concomitant)
70/M COPD, HTN, CRI, 7 235 Entire DTA Talent/5 AAA (3 y before)
Lung/prostate cancer
69/M COPD, CAD, HTN 7 275 Entire DTA Talent/3 AAA (6 y before)
F, Female; M, male; COPD, chronic obstructive pulmonary disease; DTA, descending thoracic aorta; HTN, hypertension; CRI, chronic renal insufficiency;
CAD, coronary artery disease.
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repair of TAA include long-segment thoracic aortic exclu-
sion and concomitant or previous abdominal or thoracic
aortic replacement. The reported series of endovascular
TAA repair are few, and those experiencing neurologic
deficit are infrequent. Examination of available data has
directed us to employ cerebrospinal fluid drainage and
intravenous steroid therapy as preoperative adjunctive
measures in patients at high risk. Maintenance of hemody-
namic stability in the perioperative period is paramount.
Because delays in the onset of the neurologic deficit have
been encountered after endovascular TAA repair, careful
follow-up with neurologic examination and institution of
cerebrospinal fluid drainage upon the first signs of deficit
may positively affect the outcome. Determination of the
mechanisms of action and the success of application of
adjuncts to prevent neurologic deficit in endovascular
repair of TAA await further study.
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Dr G. Melville Williams (Baltimore, Md). I stand to compli-
ment Dr Gravereaux and the group at Mount Sinai for a very
interesting paper. It reads well, and I thank them for sending me
a copy well ahead of time.
The initial reports of stent graft repairs of descending tho-
racic aortic aneurysms disclosed a surprisingly low incidence of
ischemic spinal cord problems. We have studied the blood supply
to the spinal cord angiographically in about 260 patients, and it
seemed most likely to us that at least 10% of the patients having
the entire descending thoracic aorta covered might develop neu-
romuscular dysfunction.
The great radicular artery, or artery of Adamkeiwicz, demon-
strated in this slide, originates from an intercostal, runs up to join
the anterior spinal artery in this place, and not only perfuses cau-
dally, but cranially. I propose that taking this artery out of the cir-
culation would cause spinal cord infaction. However, the major-
ity of the arteries of Adamkeiwicz only perfuse distally, meaning
that there is a substantial enough contribution from the head to
influence perfusion down to this level, or even more caudally.
There is a rich collateral circulation between intercostal arter-
ies, and in over half the patients studied, the artery of
Adamkeiwicz is small or absent. Both of these factors provide lee-
way for operative repairs.
The fact that there is an association between the loss of lum-
bar arteries as a consequence of abdominal aortic aneurysm repair
and paraplegia suggests that lumbar collaterals, or any collaterals
feeding the paraspinal network, are important.
What is truly surprising in this report is the very delayed
onset of paraplegia in one of these three patients. I wonder if the
authors would agree with me that this extremely delayed form of
DISCUSSION
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paraplegia is a failure of the collateral circulation? Might this be
the outcome of sealing of a type II endoleak which might be good
for the aneurysm but bad for the spinal cord?
Finally, we continue to believe in the value of identifying the
spinal cord blood supply preoperatively and have had no inci-
dence of significant neurological dysfunction in the large number
of patients we have studied. The procedure is not as arduous as it
may seem because of the collaterals existing between the inter-
costal vessels. Consequently, the injection of T10 is likely to dis-
close an important contribution to the spinal cord arising from
T9. Further, the case of fusiform aneurysms associated with mural
thrombus, few intercostals remain, which limits the number that
need to be studied.
Thank you.
Dr Edwin C. Gravereaux. Thank you, Dr Williams, for that
review of the anatomical considerations which are obviously very
important, especially in the application of this technique to tho-
racic aortic aneurysms.
Regarding the delayed onset, thrombosis of a collateral ves-
sel may have contributed to the development of neurologic symp-
toms.
Dr Ramon Berguer (Detroit, Mich). As Dr Williams was say-
ing, the upper part of the spinal cord receives its supply from the
anterior spinal artery, and this artery is, of course, the first branch
of the intracranial portion of each vertebral artery. Have you
checked if there is any correlation in the preoperative arterio-
grams of these three patients as to whether both vertebrals were
absent? Or, in addition to that, whether you did any manipulation
with the subclavian, such as a transposition, that might have influ-
enced the upper supply for the spinal cord?
Dr Gravereaux. That’s a very good point. In these patients,
the vertebral arteries were patent angiographically. Selective injec-
tions were not performed to evaluate the spinal arterial supply.
We did not in these three patients perform subclavian carotid
transposition. We didn’t need to because we had adequate landing
zones for the endograft. That has been performed in five patients
at Mount Sinai, and they did not develop any neurologic deficits.
Dr Thomas S. Riles (New York, NY). I enjoyed the paper
very much, and it’s amazing how much you can learn from very
good case presentations, sometimes without having to have lots
of numbers.
It is important to note that also with abdominal aortic
aneurysm repair using the endografts, there have been reported
cases of paralysis and infarction of the spinal cord. Most of these
are immediate onset. And the incidence seems to be higher with
the endograft than it would be for open repair. In those cases it is
likely to be related to embolization while the graft is being
unsheathed in the suprarenal aorta. And I wanted to know if
you’ve thought a little bit about the mechanism and if you’ve had
any paralysis in the abdominal aortic aneurysm cases as well.
Thank you.
Dr Gravereaux. I am not aware of any cases of paraplegia
developing after infrarenal aneurysm repair at Mount Sinai.
However, embolism certainly can play a part. We did have two
patients with thoracic endografts experiencing clinically signifi-
cant embolic complications. One experienced a common femoral
artery embolism with leg ischemia and one did have colon
ischemia. So embolization might be postulated as a reason for an
immediate-onset neurologic deficit.
Dr Riles. In the infrarenal aneurysms in our experience we’ve
had the one case of acute onset paraplegia for an infrarenal endo-
graft placement. That particular patient’s course was complicated—
it was an acute situation where the patient had an aortocaval fistula
from bilateral large common iliac aneurysms. I actually tried to do
a bypass from the external to the internal iliac artery on one side,
but this inflammatory mess in the pelvis was just huge and we could
not expose that adequately. We covered both hypogastrics in that
particular situation and that patient wound up with paralysis. But
that’s the only way. We have not seen it in the otherwise uncom-
plicated endovascular infrarenal repairs.
Dr John J. Ricotta (Stony Brook, NY). Could you find incit-
ing events in these patients? I mean, were they hypotensive? Were
they on β blockers? Was there something that might have
induced, particularly in the late events, some systemic hypoten-
sive response?
Given the experience of your institution with delayed para-
plegia after open repair, how long do you think people should be
kept in the hospital and should they all have spinal drainage and
should the spinal drainage be continued for a period of time after
endovascular repair?
Dr Gravereaux. As far as inciting events, the first patient with
the misdeployed thoracic endovascular device had a period of
aortic occlusion because of the cross-clamping and the infrarenal
tube graft repair. In addition, the temporary visceral segment
occlusion may have caused a secondary ischemic response similar
to an open thoracoabdominal surgical repair.
With the case of very delayed onset, it does seem likely that
thrombosis of a marginal spinal cord artery that was patent
immediately after endograft deployment is to blame. There was
no specific hypotension noted in either of his two occurrences.
The third patient with the postop day 2 onset had no obvi-
ous inciting event noted.
Dr Ricotta. How long are you keeping these people in the hos-
pital now, and are you draining all of them; and if so, for how long?
Dr Gravereaux. The drainage recommendations as outlined
by Dr Marin and Dr Hollier are currently used for patients with
extensive coverage of the thoracic aorta, and especially those with
concomitant or prior abdominal aortic aneurysm repair.
The CSF drain is left in place over night to maintain an
intrathecal pressure ≤10 mm Hg. If evidence of hemodynamic
instability or other potential causes of spinal ischemia are present,
the drain may be maintained for up to 72 hours.
Dr Thomas F. Panetta (Brooklyn, NY). I enjoyed the paper
very much. And it seems to be something very real, and I agree
it’s very perplexing, too. If you look at the Stanford series, there
were 153 cases performed. And of the five cases that had para-
plegia with a 3.3% incidence, all five patients likewise had
infrarenal aortic aneurysm repair. The analysis of the data showed
two factors as independent variables and those were previous
infrarenal aortic aneurysm repair and the length of the stents in
the descending thoracic aorta.
I may have missed it in your presentation, but could you
comment on the lengths? And again the implication is that this is
clearly a combination of collaterals between the intercostals and
the lumbars supplying the spinal cord.
Dr Gravereaux. The first patient had 160 mm of descending
thoracic aorta covered from the mid-descending down to just
proximal to the celiac axis.
The other two patients had more substantial lengths—one
was 275 mm, the other one was 230 mm. But importantly, given
tortuosity, the actual length of the endograft is probably less
important than the anatomic extent. So from the left subclavian
artery down to the celiac axis is what we’re using as a definition
anatomically of extensive thoracic coverage.
Dr Larry H. Hollier (New York, NY). This is still a perplex-
ing issue. Of the 53 patients in whom we placed thoracic endo-
grafts, we’ve had three with neurologic deficits. But there were
50 without neurologic deficits and many of those covered the
entire thoracic aorta from the subclavian down to the celiac, and
those patients did not get neurologic deficit.
So this brings into question the common thought and belief
that we’ve all had regarding the importance of the artery of
Adamkiewicz. I think we do not appreciate the significance of
collateral circulation to the spinal cord. And in all the endovas-
cular series reported with neurologic deficits, one of the major
risk factors is previous infrarenal aortic grafting. So if that set of
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collaterals has been removed, perhaps that’s one less area of col-
lateral flow that you can derive from this.
In our experience, and in others that have been published or
submitted for publication in the literature, CSF drainage, if it’s
done immediately, has often reversed the spinal ischemic findings
and reversed the paralysis. So there is some suggestion that this
might need to be done on a routine basis, particularly if you’re
going to cover extensive amounts, and especially if the patient has
had a previous infrarenal aneurysm repair.
So in my protocol I put in CSF drainage at the time of
surgery and I leave it for 24 hours; if they’ve had previous
infrarenal graft repair, I just plan on those patients staying in for
3 days and I treat them the way I do my open thoracoabdomi-
nals with 3 days of CSF drainage.
Dr Williams. I just have one added comment. Nineteen
patients had extensive thoracoabdominal aneurysm repairs,
and two developed paraplegia. So that’s an incidence of
10%. This is what I would predict on the basis of finding
about 10% of the patients having a very, very significant
contribution to the anterior spinal artery. The rest of them
really don’t. But that 1 in 10 is the one that’s going to
plague us.
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